IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2023 Holdings

Filed 2023-11-15 | 12 holdings | $41.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$41.2M160,48099.4%
United Therapeutics Corp(UTHR)COM91307C102$45.5K201,2220.1%
Exelixis Inc(EXEL)COM30161Q104$41.5K1,899,1510.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$38.9K47,2560.1%
Alkermes PLC(ALKS)COMG01767105$25.4K906,0600.1%
Cardinal Health Inc(CAH)COM14149Y108$25.3K291,3190.1%
Taro Pharmaceutical IndusCOMM8737E108$24.2K640,7350.1%
Embecta Corp(EMBC)COM29082K105$17.5K1,164,8760.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$8.2K735,1030.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$1.8K112,6660.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$1.6K360,4290.0%
Kodiak Sciences Inc(KOD)COM50015M109$616342,3120.0%